Grants Awarded

Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA #sort ascending PI/Project Leader Institution Title Status
2023 R33 RFA-CA-22-004 DUNCAVAGE, ERIC J WASHINGTON UNIVERSITY A Rapid and Comprehensive Approach for Clinical Genomic Profiling in Lung Cancer Active
2023 R33 RFA-CA-22-004 LEVENSON, RICHARD M UNIVERSITY OF CALIFORNIA AT DAVIS CoreView and FIBI for rapid-onsite evaluation and molecular profiling of core-needle breast biopsies. Active
2023 R33 RFA-CA-22-004 BRUDNO, YEVGENY NORTH CAROLINA STATE UNIVERSITY RALEIGH MASTER Scaffolds for Rapid, Single-Step Manufacture and Prototyping of CAR-T cells Active
2023 R33 RFA-CA-22-002 LABAER, JOSHUA ARIZONA STATE UNIVERSITY-TEMPE CAMPUS Multiplex In-Solution Protein Array (MISPA) for high throughput, quantitative, early profiling of pathogen-induced head and neck Active
2023 R33 RFA-CA-22-002 CUNNINGHAM, BRIAN T UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN Rapid, simple, and ultrasensitive quantitation of KRAS ctDNA at the point of care using CRISPR/Cas amplification and digital resolution biosensor microscopy Active
2023 R33 RFA-CA-22-002 JI, HANLEE P STANFORD UNIVERSITY Single cell modeling of cancer mutations Active
2023 R33 RFA-CA-22-002 MEYER, KATHRYN D DUKE UNIVERSITY A High-Throughput Screening Platform to Discover RNA Methylation Inhibitors Active
2023 R33 RFA-CA-22-002 WEISSLEDER MD PHD, RALPH MASSACHUSETTS GENERAL HOSPITAL Bioorthogonal probe development for highly parallel in vivo imaging Active
2023 R33 RFA-CA-22-002 VAN GALEN, PETER BRIGHAM AND WOMEN'S HOSPITAL Clonal analysis of cancer by mitochondrial DNA barcoding Active
2023 R33 RFA-CA-22-002 ISSADORE, DAVID AARON UNIVERSITY OF PENNSYLVANIA Combining Machine Learning and Nanofluidic Technology for The Multiplexed Diagnosis of Pancreatic Adenocarcinoma Active
2023 R33 RFA-CA-22-002 MURETTA, JOSEPH M UNIVERSITY OF MINNESOTA Engineering Protein Modulators of Notch Activation for T-cell immunotherapy Active
2023 R33 RFA-CA-22-002 KLEIN, ALLON MOSHE HARVARD MEDICAL SCHOOL Micro-capsules for versatile multiplexed cytometry Active
2023 R61 RFA-CA-22-001 SHIRURE, VENKTESH UNIVERSITY OF CALIFORNIA AT DAVIS Microfluidic technology to isolate tumoricidal T-cells from peripheral blood Active
2023 R61 RFA-CA-22-001 GAO, XIAOJING J STANFORD UNIVERSITY Program the Immune System against RAS-driven Cancer Active
2023 R61 RFA-CA-22-001 SHAH, NEEL H COLUMBIA UNIV NEW YORK MORNINGSIDE A Generalizable Photo-Crosslinking Strategy to Identify Tyrosine Phosphatase Substrates Active
2023 R61 RFA-CA-22-001 DHAKAL, SOMA VIRGINIA COMMONWEALTH UNIVERSITY Single-Molecule High-Confidence Detection of miRNA Cancer Biomarkers Active
2023 R61 RFA-CA-22-001 LU, YUE UNIVERSITY OF UTAH Vesicle Epitope Transcript sequencing (VET-seq): Droplet-based Multiomic Profiling Platform for Single Vesicle Analysis Active
2023 R61 RFA-CA-22-001 PRATX, GUILLEM STANFORD UNIVERSITY A Novel Assay to Individualize Resensitization of Iodine-Refractory Thyroid Cancer Active
2023 R61 RFA-CA-22-001 CAMPAGNOLA, PAUL J UNIVERSITY OF WISCONSIN-MADISON A novel multimodal ECM analysis platform for tumor characterization combining morphological and spectrochemical tissue imaging approaches. Active
2023 R61 RFA-CA-22-001 HACOHEN, NIR BROAD INSTITUTE, INC. Development of methods for highly multiplexed quantification of cancer proteomes using large-scale nanobody libraries Active
2023 R61 RFA-CA-22-001 YAN, HAO ARIZONA STATE UNIVERSITY-TEMPE CAMPUS High-throughput, purification-free, and ultrasensitive transmembrane nanosensor arrays for digital counting of microRNA biomarkers of intact exosomes Active
2023 R61 RFA-CA-22-001 LUKER, GARY D UNIVERSITY OF MICHIGAN AT ANN ARBOR Integrated Imaging Tools for Intercellular Chemokine Signalling Active
2023 R61 RFA-CA-22-001 BRAVO CORDERO, JOSE JAVIER ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI Intersectional genetics-based biosensors for dormant cancer cells Active
2022 R21 RFA-CA-21-005 SHIBATA, DARRYL K UNIVERSITY OF SOUTHERN CALIFORNIA Photolithographic Tumor DNA Isolation Active
2022 R21 RFA-CA-21-005 TANG, SINDY KAM-YAN STANFORD UNIVERSITY A micro-dissection platform for generating uniform-sized patient-derived tumor organoids (PDOs) for personalized cancer therapy Active
2022 R33 RFA-CA-21-004 LEE, ABRAHAM P UNIVERSITY OF CALIFORNIA-IRVINE Microfluidic Precision Engineered Artificial Antigen Presenting Cells for Cancer Immunotherapy Active
2022 R33 RFA-CA-21-004 WANG, TZA-HUEI JEFF JOHNS HOPKINS UNIVERSITY A low-cost, multiplexed digital high resolution melt platform for DNA methylation-based detection and identification of cancers in liquid biopsies Active
2022 R33 RFA-CA-21-004 PAN, TAO UNIVERSITY OF CHICAGO Transfer RNA sequencing and application to cancer research and clinics Active
2022 R33 RFA-CA-21-004 NAEGLE, KRISTEN M UNIVERSITY OF VIRGINIA A synthetic toolkit for the recombinant production of tyrosine phosphorylated proteins and peptides Active
2022 R33 RFA-CA-21-004 LANDAU, DAN WEILL MEDICAL COLL OF CORNELL UNIV Expanding the GoT toolkit to link single-cell clonal genotypes with protein, transcriptomic, epigenomic and spatial phenotypes Active
2022 R21 RFA-CA-21-003 YAKOVLEV, VLADISLAV V TEXAS ENGINEERING EXPERIMENT STATION Molecular and cellular imaging of bone biopsies using AI augmented deep UV Raman microscopy Active
2022 R21 RFA-CA-21-003 SOPER, STEVEN ALLAN UNIVERSITY OF KANSAS LAWRENCE Molecular Sub-typing Breast Cancer Patients using a Liquid Biopsy Active
2022 R21 RFA-CA-21-003 KNOWLES, DAVID ARTHUR NEW YORK GENOME CENTER A CRISPR/Cas13 approach for identifying individual transcript isoform function in cancer Active
2022 R21 RFA-CA-21-003 GIBBS, SUMMER LYNNE OREGON HEALTH & SCIENCE UNIVERSITY A Novel Fluorescence Imaging Platform to Predict Response to Combinatorial Tyrosine Kinase Inhibitors Active
2022 R21 RFA-CA-21-003 SALIPANTE, STEPHEN J UNIVERSITY OF WASHINGTON Efficient, cost-effective, and ultrasensitive sequencing of somatic mutations Active
2022 R21 RFA-CA-21-003 NABA, ALEXANDRA UNIVERSITY OF ILLINOIS AT CHICAGO Enhanced mass-spectrometry-based approaches for in-depth profiling of the cancer extracellular matrix Active
2022 R21 RFA-CA-21-003 KELLY, RYAN T BRIGHAM YOUNG UNIVERSITY In-depth and label-free proteome profiling of hundreds of single cells per day Active
2021 R33 RFA-CA-20-020 HAUN, JERED BRACKSTON UNIVERSITY OF CALIFORNIA-IRVINE Microfluidic tumor tissue processing platform for single cell diagnostics Active
2021 R21 RFA-CA-20-019 SANTORE, MARIA M UNIVERSITY OF MASSACHUSETTS AMHERST Paper-based Breastmilk Collection System for Facile, In-Home Use Active
2021 R33 RFA-CA-20-018 JI, HANLEE P STANFORD UNIVERSITY Multimodal iterative sequencing of cancer genomes and single tumor cells Active
2021 R33 RFA-CA-20-018 GARTNER, ZEV JORDAN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO Universal Sample Multiplexing for Single Cell Analysis Active
2021 R33 RFA-CA-20-018 SEELIG, GEORG UNIVERSITY OF WASHINGTON Joint receptor and protein expression immunophenotyping through split-pool barcoding Active
2021 R33 RFA-CA-20-018 GREENBERG, JOEL DUKE UNIVERSITY Multimodality X-ray transmission and diffraction scanner for molecular analysis of cancer specimens Active
2021 R33 RFA-CA-20-018 HANSEN, ANDERS SEJR MASSACHUSETTS INSTITUTE OF TECHNOLOGY Super-resolution microscopy for dynamic analysis of focal enhancer amplifications in cancer Active
2021 R33 RFA-CA-20-018 LIU, XUEFENG OHIO STATE UNIVERSITY Validating Urine Derived Cancer Cells (UDCC) -- Non-Invasive and Living Liquid Biopsies -- in Bladder Cancer Clinics Active
2021 R21 RFA-CA-20-017 WILSON, GERALD M UNIVERSITY OF MARYLAND BALTIMORE Suppressing oncogenic RNA regulons using engineered zinc finger ribonucleases Active
2021 R21 RFA-CA-20-017 ZHANG, FANGLIANG UNIVERSITY OF MIAMI SCHOOL OF MEDICINE Targeted degradation of proteins by affinity peptide conjugated ubiquitin (APCU) Active
2021 R21 RFA-CA-20-017 STILL, AMANDA NICOLE HAYMOND GEORGE MASON UNIVERSITY New Hybrid Molecular Modalities Comprised of DNA-Origami and Interfering Peptides as Inhibitors of Protein-Protein Interactions Active
2021 R21 RFA-CA-20-017 XIAO, HAN RICE UNIVERSITY Development of Bone-Targeting Antibodies for Ewing Sarcoma Using Genetic Code Expansion Active
2021 R21 RFA-CA-20-017 SWAGER, TIMOTHY M MASSACHUSETTS INSTITUTE OF TECHNOLOGY Innovative Droplet Lenses for NextGen Light Sensors of Biomarkers of Inflammation Active